US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

0.5000

-0.0500-9.09%

Post-market: 0.50270.0027+0.54%19:29 EST

Volume:1.61M

Turnover:838.16K

Market Cap:20.32M

PE:-0.31

High:0.5561

Open:0.5561

Low:0.5000

Close:0.5500

52wk High:8.19

52wk Low:0.4610

Shares:40.63M

Float Shares:33.99M

Volume Ratio:0.45

T/O Rate:4.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6003

EPS(LYR):2.69

ROE:-24.07%

ROA:-10.87%

PB:0.25

PE(LYR):0.19

Loading ...

Overview Company News Filings

SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

Scienture announces repayment, conversion of outstanding debentures

SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet

Scienture Holdings Lowers Quorum Requirement for Shareholder Meetings

Scienture Holdings Announces Full Conversion of Debentures to Common Stock, Eliminating Debt Obligations

BRIEF-Scienture Holdings Secures GPO Agreements For Arbli Accessing 2500 Institutions

Scienture Holdings Inc - Secures Gpo Agreements for Arbli Accessing 2500 Institutions

THOMSON REUTERS

SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare Institutions

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Benzinga_recent_news

Scienture Holdings Inc. Enters Equity Distribution Agreement for $9.2 Million Share Offering with Maxim Group LLC

Scienture Secures Rebate Deal to Promote Stroke and Diabetes Drug Adoption

MT Newswires Live

Scienture Secures Pbm-Led Gpo Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(Losartan Potassium) in the $256M U.S. Losartan Market

THOMSON REUTERS

SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market

Scienture Holdings Inc. Announces Sale of 3,225,000 Shares in $3.9 Million Direct Offering

Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock

Scienture Announces the Shipment of Launch Quantities of Arbli™ (Losartan Potassium Oral Suspension) to Its 3Pl/Distribution Center and Receipt of First Wholesaler Order, Marking Major Commercialization Milestones.

THOMSON REUTERS

SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.

Scienture Holdings Q2 EPS $(0.48) Up From $(1.16) YoY

Scienture Holdings Inc : Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS

BRIEF-Scienture Holdings Secures $1.2 Million In Bridge Funding

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCNX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.5,"timestamp":1766005200000,"preClose":0.55,"halted":0,"volume":1611988,"hourTrading":{"tag":"盘后","latestPrice":0.5027,"preClose":0.5,"latestTime":"19:29 EST","volume":26103,"amount":13273.47312522,"timestamp":1766017783371},"delay":0,"floatShares":33992500,"shares":40630815,"eps":-1.600281,"marketStatus":"Post-Mkt","change":-0.05,"latestTime":"12-17 19:35:42 EST","open":0.5561,"high":0.5561,"low":0.5,"amount":838160.7369436,"amplitude":0.102,"askPrice":0.5253,"askSize":45,"bidPrice":0.5,"bidSize":12287,"shortable":3,"etf":0,"ttmEps":-1.600281,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":4,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.55,"preHourTrading":{"tag":"盘前","latestPrice":0.5501,"preClose":0.55,"latestTime":"09:08 EST","volume":19488,"amount":10728.676607039999,"timestamp":1765980480708},"postHourTrading":{"tag":"盘后","latestPrice":0.5027,"preClose":0.5,"latestTime":"19:29 EST","volume":26103,"amount":13273.47312522,"timestamp":1766017783371},"volumeRatio":0.451173},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","floatShares":33992500,"roa":"-10.87%","roe":"-24.07%","lyrEps":2.685903,"volumeRatio":0.451173,"shares":40630815,"dividePrice":0,"high":0.5561,"amplitude":0.102,"preClose":0.55,"low":0.5,"week52Low":0.461,"pbRate":"0.25","psRate":"31.09","week52High":8.19,"institutionHeld":0,"latestPrice":0.5,"committee":0.992702,"eps":-1.600281,"divideRate":0,"volume":1611988,"delay":0,"ttmEps":-1.600281,"open":0.5561,"prevYearClose":6.05,"prevWeekClose":0.6054,"prevMonthClose":0.5991,"prevQuarterClose":0.8495,"fiveDayClose":0.6326,"twentyDayClose":0.6277,"sixtyDayClose":0.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"SCNX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"SCNX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-05-12","symbol":"SCNX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-03-26","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"SCNX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-1.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNX\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-25","recordDate":"2024-03-18","paymentDate":"2024-03-22","value":8,"currency":"USD"},{"executeDate":"2024-07-19","recordDate":"2024-07-19","paymentDate":"2024-07-24","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNX","date":"2025-12-16","current":-0.320944,"percent":0.254072,"low":-4.335221,"twenty":-1.204534,"median":-0.766203,"eighty":1.552225,"high":3.580326,"avg":-0.020955,"sd":1.829179,"marketCap":22346948},"quantilePoints":[{"date":"2024-09-27","current":-0.598388,"twenty":-0.613397,"median":-0.60738,"eighty":-0.601331,"marketCap":10677383},{"date":"2024-10-04","current":-0.575439,"twenty":-0.613397,"median":-0.603293,"eighty":-0.596854,"marketCap":10267882},{"date":"2024-10-11","current":-0.569717,"twenty":-0.610449,"median":-0.596691,"eighty":-0.575112,"marketCap":10165786},{"date":"2024-10-18","current":-3.316594,"twenty":-3.320439,"median":-0.603293,"eighty":-0.579563,"marketCap":59179885},{"date":"2024-10-25","current":-3.532893,"twenty":-3.381003,"median":-0.61388,"eighty":-0.587997,"marketCap":63039443},{"date":"2024-10-31","current":-3.835472,"twenty":-3.470407,"median":-1.920019,"eighty":-0.593421,"marketCap":68438535},{"date":"2024-11-08","current":-3.92083,"twenty":-3.680939,"median":-3.316594,"eighty":-0.596527,"marketCap":69961625},{"date":"2024-11-15","current":3.401097,"twenty":-3.547313,"median":-1.920019,"eighty":-0.574948,"marketCap":68584767},{"date":"2024-11-22","current":3.456572,"twenty":-3.511744,"median":-0.611468,"eighty":3.395976,"marketCap":69703464},{"date":"2024-11-29","current":3.136519,"twenty":-3.477174,"median":-0.603293,"eighty":3.362691,"marketCap":63249440},{"date":"2024-12-06","current":3.110915,"twenty":-3.463831,"median":-0.596691,"eighty":3.285878,"marketCap":62733118},{"date":"2024-12-13","current":3.337086,"twenty":-3.450219,"median":-0.582313,"eighty":3.360949,"marketCap":67293962},{"date":"2024-12-20","current":3.469375,"twenty":-3.422821,"median":-0.572987,"eighty":3.384019,"marketCap":69961625},{"date":"2024-12-27","current":2.837803,"twenty":-3.405517,"median":1.134043,"eighty":3.366915,"marketCap":57225683},{"date":"2025-01-03","current":2.561875,"twenty":-3.372831,"median":2.613767,"eighty":3.343052,"marketCap":51661454},{"date":"2025-01-10","current":2.200068,"twenty":-3.341588,"median":2.571818,"eighty":3.331965,"marketCap":44365450},{"date":"2025-01-17","current":1.983099,"twenty":-3.320439,"median":2.304552,"eighty":3.323431,"marketCap":39990159},{"date":"2025-01-24","current":1.820372,"twenty":-3.285831,"median":2.061208,"eighty":3.308922,"marketCap":36708691},{"date":"2025-01-31","current":1.69236,"twenty":-3.231997,"median":1.995032,"eighty":3.279477,"marketCap":34127269},{"date":"2025-02-07","current":1.431997,"twenty":-2.180107,"median":1.896311,"eighty":3.250031,"marketCap":28876920},{"date":"2025-02-14","current":1.375585,"twenty":-0.618263,"median":1.823627,"eighty":3.227841,"marketCap":27739344},{"date":"2025-02-21","current":1.184652,"twenty":-0.615326,"median":1.76613,"eighty":3.213059,"marketCap":23889088},{"date":"2025-02-28","current":1.145598,"twenty":-0.611128,"median":1.69236,"eighty":3.194897,"marketCap":23101536},{"date":"2025-03-07","current":1.045792,"twenty":-0.608474,"median":1.646775,"eighty":3.193463,"marketCap":21088902},{"date":"2025-03-14","current":0.538084,"twenty":-0.602312,"median":1.540482,"eighty":3.184314,"marketCap":10850721},{"date":"2025-03-21","current":0.733356,"twenty":-0.598212,"median":1.425488,"eighty":3.168951,"marketCap":14788483},{"date":"2025-03-28","current":0.715999,"twenty":-0.597181,"median":1.375585,"eighty":3.16127,"marketCap":14438460},{"date":"2025-04-04","current":1.435684,"twenty":-0.595056,"median":1.425488,"eighty":3.153589,"marketCap":13015619},{"date":"2025-04-11","current":1.12784,"twenty":-0.589891,"median":1.375585,"eighty":3.136519,"marketCap":10224770},{"date":"2025-04-17","current":1.246836,"twenty":-0.582313,"median":1.328698,"eighty":3.136519,"marketCap":11303565},{"date":"2025-04-25","current":1.311304,"twenty":-0.575439,"median":1.30873,"eighty":3.110915,"marketCap":11888016},{"date":"2025-05-02","current":1.325247,"twenty":-0.574621,"median":1.311304,"eighty":3.085311,"marketCap":12014418},{"date":"2025-05-09","current":1.290735,"twenty":-0.571352,"median":1.304933,"eighty":2.846338,"marketCap":11701542},{"date":"2025-05-16","current":-0.774291,"twenty":-0.575439,"median":1.297499,"eighty":2.837803,"marketCap":11803474},{"date":"2025-05-23","current":-0.765773,"twenty":-0.597508,"median":1.28756,"eighty":2.645772,"marketCap":11673621},{"date":"2025-05-30","current":-0.779626,"twenty":-0.610109,"median":1.27693,"eighty":2.645772,"marketCap":11884796},{"date":"2025-06-06","current":-0.894836,"twenty":-0.730719,"median":1.246836,"eighty":2.594563,"marketCap":13641086},{"date":"2025-06-13","current":-0.959367,"twenty":-0.765773,"median":1.225767,"eighty":2.581761,"marketCap":14624818},{"date":"2025-06-20","current":-0.856031,"twenty":-0.771761,"median":1.212713,"eighty":2.569829,"marketCap":13049535},{"date":"2025-06-27","current":-0.841318,"twenty":-0.780624,"median":1.184652,"eighty":2.512356,"marketCap":12825244},{"date":"2025-07-03","current":-1.247608,"twenty":-0.792738,"median":1.179469,"eighty":2.409427,"marketCap":19018822},{"date":"2025-07-11","current":-1.411087,"twenty":-0.813268,"median":1.154073,"eighty":2.262758,"marketCap":21510943},{"date":"2025-07-18","current":-1.789672,"twenty":-0.855997,"median":1.145598,"eighty":2.175929,"marketCap":27282172},{"date":"2025-07-25","current":-1.746651,"twenty":-0.908602,"median":1.122616,"eighty":2.108316,"marketCap":26626350},{"date":"2025-08-01","current":-1.669213,"twenty":-0.977436,"median":1.076168,"eighty":2.04385,"marketCap":25445872},{"date":"2025-08-08","current":-2.380911,"twenty":-1.247608,"median":1.000228,"eighty":2.013475,"marketCap":36295155},{"date":"2025-08-15","current":-0.96959,"twenty":-1.381833,"median":0.872216,"eighty":1.999328,"marketCap":19518727},{"date":"2025-08-22","current":-0.980842,"twenty":-1.373229,"median":0.796277,"eighty":1.985962,"marketCap":19745239},{"date":"2025-08-29","current":-0.980746,"twenty":-1.319883,"median":0.733356,"eighty":1.970949,"marketCap":19743303},{"date":"2025-09-05","current":-0.893537,"twenty":-1.247608,"median":0.689962,"eighty":1.941441,"marketCap":17987698},{"date":"2025-09-12","current":-0.924958,"twenty":-1.220075,"median":0.629211,"eighty":1.895443,"marketCap":18620241},{"date":"2025-09-19","current":-0.916402,"twenty":-1.093717,"median":0.546763,"eighty":1.883542,"marketCap":18448004},{"date":"2025-09-26","current":-0.858058,"twenty":-1.027837,"median":-0.570534,"eighty":1.845235,"marketCap":17273474},{"date":"2025-10-03","current":-0.892899,"twenty":-1.021738,"median":-0.575439,"eighty":1.825579,"marketCap":17974872},{"date":"2025-10-10","current":-0.787446,"twenty":-1.012393,"median":-0.59383,"eighty":1.815599,"marketCap":15852002},{"date":"2025-10-17","current":-0.608083,"twenty":-1.007669,"median":-0.598388,"eighty":1.784356,"marketCap":12241257},{"date":"2025-10-24","current":-2.680141,"twenty":-1.007669,"median":-0.596691,"eighty":1.730959,"marketCap":53953668},{"date":"2025-10-31","current":-0.791363,"twenty":-1.019031,"median":-0.603293,"eighty":1.707894,"marketCap":15930858},{"date":"2025-11-07","current":-1.280832,"twenty":-1.093717,"median":-0.610618,"eighty":1.69236,"marketCap":25784310},{"date":"2025-11-14","current":-1.151144,"twenty":-1.207623,"median":-0.619577,"eighty":1.689756,"marketCap":23173577},{"date":"2025-11-21","current":-1.10301,"twenty":-1.174718,"median":-0.731804,"eighty":1.679333,"marketCap":22671994},{"date":"2025-11-28","current":-1.184253,"twenty":-1.184253,"median":-0.746883,"eighty":1.679299,"marketCap":24341921},{"date":"2025-12-05","current":-1.19809,"twenty":-1.186625,"median":-0.754071,"eighty":1.614251,"marketCap":24626336},{"date":"2025-12-12","current":-1.198288,"twenty":-1.205799,"median":-0.765773,"eighty":1.560053,"marketCap":24630400},{"date":"2025-12-16","current":-1.087196,"twenty":-1.204534,"median":-0.766203,"eighty":1.552225,"marketCap":22346948}],"updateTime":1766002062231},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575419597","title":"SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers","url":"https://stock-news.laohu8.com/highlight/detail?id=2575419597","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575419597?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:00","pubTimestamp":1760619600,"startTime":"0","endTime":"0","summary":"Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, creat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/16/3167950/0/en/SCIENTURE-S-Arbli-Becomes-First-FDA-Approved-Ready-to-Use-Liquid-Losartan-Available-Through-Major-U-S-Wholesalers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARB","SCNX","BK4167"],"gpt_icon":0},{"id":"2573267099","title":"Scienture announces repayment, conversion of outstanding debentures","url":"https://stock-news.laohu8.com/highlight/detail?id=2573267099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573267099?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:15","pubTimestamp":1759929330,"startTime":"0","endTime":"0","summary":"SCIENTURE (SCNX) entered into an agreement with Arena Finance Markets, LP and Arena Special Opportunities III to fully discharge all outstanding ba...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-announces-repayment-conversion-of-outstanding-debentures-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-announces-repayment-conversion-of-outstanding-debentures-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2573926539","title":"SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2573926539","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573926539?lang=en_us&edition=fundamental","pubTime":"2025-10-08 21:00","pubTimestamp":1759928400,"startTime":"0","endTime":"0","summary":"COMMACK, NY, Oct.  08, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced va","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163413/0/en/SCIENTURE-Holdings-Announces-Full-Repayment-and-Conversion-of-Outstanding-Debentures-Strengthening-Balance-Sheet.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2573986606","title":"Scienture Holdings Lowers Quorum Requirement for Shareholder Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2573986606","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573986606?lang=en_us&edition=fundamental","pubTime":"2025-10-07 05:26","pubTimestamp":1759785972,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc. announced that its board of directors has approved an amendment to the company's bylaws, reducing the quorum requirement for stockholder meetings from a majority of voting stock to one-third. The change is intended to make it easier to conduct official business at stockholder meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL7pyDQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2572185635","title":"Scienture Holdings Announces Full Conversion of Debentures to Common Stock, Eliminating Debt Obligations","url":"https://stock-news.laohu8.com/highlight/detail?id=2572185635","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572185635?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:51","pubTimestamp":1759524671,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc. has announced a major amendment to its outstanding debt held by Arena Finance Markets, LP and Arena Special Opportunities III LP. Under a new agreement, the conversion price of the company's 10% original issue discount secured convertible debentures has been set at $2.4861 per share. Both Arena Investors have agreed to fully convert the remaining amounts owed under these debentures into common stock of Scienture Holdings. Upon completion of this conversion, all related obligations and security interests will be fully satisfied and released, and the debentures, along with related agreements, will be terminated. This move effectively eliminates the company's outstanding debt under these instruments and marks a significant step in Scienture Holdings' balance sheet restructuring.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL1lJN37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2572537098","title":"BRIEF-Scienture Holdings Secures GPO Agreements For Arbli Accessing 2500 Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2572537098","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572537098?lang=en_us&edition=fundamental","pubTime":"2025-10-01 22:37","pubTimestamp":1759329443,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Holdings Secures GPO Agreements For Arbli Accessing 2500 InstitutionsOct 1 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE HOLDINGS INC - SECURES GPO AGREEMENTS FOR ARBLI ACCESSING","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VI0XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2572534027","title":"Scienture Holdings Inc - Secures Gpo Agreements for Arbli Accessing 2500 Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2572534027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572534027?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:35","pubTimestamp":1759325754,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VI0XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2572348225","title":"SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli™ (losartan potassium) to more than 2500 Healthcare Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2572348225","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572348225?lang=en_us&edition=fundamental","pubTime":"2025-10-01 21:00","pubTimestamp":1759323600,"startTime":"0","endTime":"0","summary":"Represents potential penetration into ~ 20% of the U.S. institutional market, while broadening access across long-term care and outpatient facilities U.S. losartan market totals $256M annually with 71","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3159574/0/en/SCIENTURE-Secures-Multiple-Commercial-GPO-Agreements-Expanding-U-S-Market-Access-for-Arbli-losartan-potassium-to-more-than-2500-Healthcare-Institutions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARB","LABU","XBI","XLV","BK4581","SCNX","HCSG","BK4137","BK4167","BK4585","BK4588"],"gpt_icon":0},{"id":"2572531055","title":"EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2572531055","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572531055?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:46","pubTimestamp":1759322760,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. announced GPO agreements for its new drug, Arbli, providing access to over 2,500 healthcare institutions and plans to expand further.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/01/Pulmonary-Hypertension-Medicine-Doctor-H.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/01/Pulmonary-Hypertension-Medicine-Doctor-H.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/10/47966068/exclusive-scienture-secures-purchase-agreements-healthcare-institutions","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/10/47966068/exclusive-scienture-secures-purchase-agreements-healthcare-institutions","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["HCSG","BK4167","XLV","BK4137","SCNX","LABU","PBM","BK4588","BK4585","XBI","BK4581","BK4139"],"gpt_icon":0},{"id":"2569746069","title":"Scienture Holdings Inc. Enters Equity Distribution Agreement for $9.2 Million Share Offering with Maxim Group LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2569746069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569746069?lang=en_us&edition=fundamental","pubTime":"2025-09-24 05:02","pubTimestamp":1758661347,"startTime":"0","endTime":"0","summary":"On September 19, 2025, Scienture Holdings, Inc. entered into an Equity Distribution Agreement with Maxim Group LLC to act as the sole sales agent for the offer and sale of the company's common stock. The agreement allows for sales of shares with an aggregate gross sales price of up to $9,200,000. The company will pay the manager a 3% commission of the gross sales price for any shares sold. No specific number of shares or transaction prices are mentioned in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLp7903:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2567100669","title":"Scienture Secures Rebate Deal to Promote Stroke and Diabetes Drug Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2567100669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567100669?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:51","pubTimestamp":1758027114,"startTime":"0","endTime":"0","summary":"Scienture Holdings  said Tuesday it has formalized a commercial Pharmacy Benefit Manager led Group Purchasing Organization rebate agreement.This agreement involves negotiating rebates with pharmaceutical manufacturers on behalf of a group of buyers, such as employers, insurers or health care plans.The agreement is expected to both expand patient access and reduce reimbursement barriers, the company said.The company said this pact is for advancing the process of securing formulary access with health plans covering more than 100 million people for Arbli  Oral Suspension, 10 mg/mL.According to Scienture Holdings, Arbli is FDA-approved for the treatment of hypertension in patients greater than six years old, for reducing the risk of stroke in patients with hypertension and left ventricular hypertrophy, and for treating diabetic nephropathy in certain patients with type 2 diabetes.It further added that additional discussions are underway to further expand both commercial and government cove","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2567102177","title":"Scienture Secures Pbm-Led Gpo Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(Losartan Potassium) in the $256M U.S. Losartan Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2567102177","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567102177?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:05","pubTimestamp":1758024300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250916:nTUA587FKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2567024581","title":"SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2567024581","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567024581?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:05","pubTimestamp":1758024300,"startTime":"0","endTime":"0","summary":"Arbli is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life COMMACK, NY,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/16/3150769/0/en/SCIENTURE-Secures-PBM-Led-GPO-Rebate-Agreement-to-Drive-Expanded-Commercial-Coverage-and-Formulary-Access-for-Arbli-losartan-potassium-in-the-256M-U-S-Losartan-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SCNX","ARB","BK4167","PBM"],"gpt_icon":0},{"id":"2559949304","title":"Scienture Holdings Inc. Announces Sale of 3,225,000 Shares in $3.9 Million Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2559949304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559949304?lang=en_us&edition=fundamental","pubTime":"2025-08-16 05:11","pubTimestamp":1755292282,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc.  announced a securities purchase agreement with certain institutional investors to buy 3,225,000 shares of common stock at $1.20 per share. The total gross proceeds from this registered direct offering are expected to be approximately $3.9 million. This transaction is set to close on August 15, 2025, with Maxim Group LLC serving as the sole placement agent.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL39m0PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2559957209","title":"Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2559957209","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559957209?lang=en_us&edition=fundamental","pubTime":"2025-08-14 21:00","pubTimestamp":1755176400,"startTime":"0","endTime":"0","summary":"Commack, NY, Aug.  14, 2025  (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/14/3133508/0/en/Scienture-Holdings-Inc-Announces-Pricing-of-3-9-Million-Registered-Direct-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2559604578","title":"Scienture Announces the Shipment of Launch Quantities of Arbli™ (Losartan Potassium Oral Suspension) to Its 3Pl/Distribution Center and Receipt of First Wholesaler Order, Marking Major Commercialization Milestones.","url":"https://stock-news.laohu8.com/highlight/detail?id=2559604578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559604578?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:05","pubTimestamp":1755086700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA9FNKSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2559860422","title":"SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.","url":"https://stock-news.laohu8.com/highlight/detail?id=2559860422","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559860422?lang=en_us&edition=fundamental","pubTime":"2025-08-13 20:05","pubTimestamp":1755086700,"startTime":"0","endTime":"0","summary":"COMMACK, NY, Aug.  13, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced val","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132560/0/en/SCIENTURE-announces-the-shipment-of-launch-quantities-of-Arbli-losartan-potassium-Oral-Suspension-to-its-3PL-Distribution-Center-and-receipt-of-first-wholesaler-order-marking-major.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARB","SCNX","BK4167"],"gpt_icon":0},{"id":"2558472396","title":"Scienture Holdings Q2 EPS $(0.48) Up From $(1.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2558472396","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558472396?lang=en_us&edition=fundamental","pubTime":"2025-08-12 21:32","pubTimestamp":1755005556,"startTime":"0","endTime":"0","summary":"Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.48) per share. This is a 58.62 percent increase over losses of $(1.16) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47058701/scienture-holdings-q2-eps-0-48-up-from-1-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX"],"gpt_icon":0},{"id":"2556467888","title":"Scienture Holdings Inc : Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556467888","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556467888?lang=en_us&edition=fundamental","pubTime":"2025-08-02 05:24","pubTimestamp":1754083496,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT398:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2554824736","title":"BRIEF-Scienture Holdings Secures $1.2 Million In Bridge Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2554824736","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554824736?lang=en_us&edition=fundamental","pubTime":"2025-07-25 06:34","pubTimestamp":1753396466,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Holdings Secures $1.2 Million In Bridge FundingJuly 24 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE HOLDINGS INC - SECURES $1.2 MILLION IN BRIDGE FUNDINGSource text: ID:nGNX3ZvdF7Further company coverage: SCNX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL2H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}